OpenMed-NER-PharmaDetect-BioMed-109M

This model is a **state-of-the-art** fine-tuned transformer engineered to deliver **enterprise-grade accuracy** for chemical entity recognition - chemical entities from the bc5cdr dataset. This specialized model excels at identifying and extracting biomedical entities from clinical texts, research papers, and healthcare documents, enabling applications such as **drug interaction detection**, **medication extraction from patient records**, **adverse event monitoring**, **literature mining for drug discovery**, and **biomedical knowledge graph construction** with **production-ready reliability** for clinical and research applications. BC5CDR-Chem focuses on chemical entity recognition from the BioCreative V Chemical-Disease Relation extraction task. The BC5CDR-Chem corpus is part of the BioCreative V Chemical-Disease Relation (CDR) extraction challenge, specifically targeting chemical entity recognition in biomedical texts. This dataset contains 1,500 PubMed abstracts with 4,409 annotated chemical entities, designed to support automated drug discovery and pharmacovigilance applications. The corpus emphasizes chemical compounds, drugs, and therapeutic substances that are relevant for understanding chemical-disease relationships. It serves as a critical resource for developing NER systems that can identify chemical entities for downstream tasks like adverse drug reaction detection and drug repurposing research.

译文尚未就绪，显示来源原文